Cancer Research Versailles No Abst  Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3592-3595, August 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batchu, R. B.
Right arrow Articles by Munshi, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batchu, R. B.
Right arrow Articles by Munshi, N. C.
[Cancer Research 59, 3592-3595, August 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Interaction of Adeno-associated Virus Rep78 with p53

Implications in Growth Inhibition1

Ramesh B. Batchu2, Masood A. Shammas2, Jing Yi Wang and Nikhil C. Munshi3

Central Arkansas Veterans Health Care System and Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Adeno-associated virus (AAV) is a nonpathogenic, single-stranded DNA virus belonging to the parvoviridae family. Onco-suppressive properties of AAV against adenovirus, a DNA tumor virus, have been well documented. Rep78, a major regulatory protein of AAV, is believed to be responsible for its antioncogenic properties. Most DNA tumor viruses disturb the cell cycle pathways by essentially abrogating the functions of p53. Here we present evidence that AAV acts as an antiproliferative agent against adenovirus by protecting the adenoviral-mediated degradation of p53 as confirmed by both Western blot analysis and immunoprecipitation analysis with anti-p53 antibody. Coimmunoprecipitation experiments revealed that the AAV Rep78 is physically bound to p53 in vivo. Furthermore, the binding of purified p53 to the AAV Rep78 affinity column confirms their interaction. These results document for the first time that the antiproliferative effects of AAV against adenovirus are mediated, at least in part, by the interaction of AAV Rep78 with p53.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. Nash, W. Chen, M. Salganik, and N. Muzyczka
Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein
J. Virol., January 1, 2009; 83(1): 454 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Alam, E. Sen, H. Brashear, and C. Meyers
Adeno-Associated Virus Type 2 Increases Proteosome-Dependent Degradation of p21WAF1 in a Human Papillomavirus Type 31b-Positive Cervical Carcinoma Line.
J. Virol., May 1, 2006; 80(10): 4927 - 4939.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Berthet, K. Raj, P. Saudan, and P. Beard
How adeno-associated virus Rep78 protein arrests cells completely in S phase
PNAS, September 20, 2005; 102(38): 13634 - 13639.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. B. Batchu, M. A. Shammas, J. Y. Wang, J. Freeman, N. Rosen, and N. C. Munshi
Adeno-associated Virus Protects the Retinoblastoma Family of Proteins from Adenoviral-induced Functional Inactivation
Cancer Res., May 1, 2002; 62(10): 2982 - 2985.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Weger, E. Hammer, and R. Heilbronn
Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression
J. Gen. Virol., March 1, 2002; 83(3): 511 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Schmidt, J. A. Chiorini, S. Afione, and R. Kotin
Adeno-Associated Virus Type 2 Rep78 Inhibition of PKA and PRKX: Fine Mapping and Analysis of Mechanism
J. Virol., February 1, 2002; 76(3): 1033 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Schmidt, S. Afione, and R. M. Kotin
Adeno-Associated Virus Type 2 Rep78 Induces Apoptosis through Caspase Activation Independently of p53
J. Virol., October 15, 2000; 74(20): 9441 - 9450.
[Abstract] [Full Text]


Home page
J. Virol.Home page
P. Ogston, K. Raj, and P. Beard
Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein
J. Virol., April 15, 2000; 74(8): 3494 - 3504.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. B. Batchu, M. A. Shammas, J. Y. Wang, and N. C. Munshi
Dual Level Inhibition of E2F-1 Activity by Adeno-associated Virus Rep78
J. Biol. Chem., June 22, 2001; 276(26): 24315 - 24322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.